Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity

Zhou, Haibin; Lu, Jianfeng; Chinnaswamy, Krishnapriya; Stuckey, Jeanne A.; Liu, Liu; McEachern, Donna; Yang, Chao-Yie; Bernard, Denzil; Shen, Hong; Rui, Liangyou; Sun, Yi; Wang, Shaomeng

doi:10.1038/s41467-021-22924-4

Title: Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity

Journal Article · Tue May 11 00:00:00 EDT 2021 · Nature Communications

DOI:https://doi.org/10.1038/s41467-021-22924-4· OSTI ID:1787786

^[1]; Lu, Jianfeng ^[1]; Chinnaswamy, Krishnapriya ^[1]; Stuckey, Jeanne A. ^[1]; Liu, Liu ^[1]; McEachern, Donna ^[1];

^[1];

^[2]; Wang, Shaomeng ^[1]

Univ. of Michigan, Ann Arbor, MI (United States)
Zhejiang Univ., Hangzhou (China)

Cullin-RING E3 ligases (CRLs) regulate the turnover of approximately 20% of mammalian cellular proteins. Neddylation of individual cullin proteins is essential for the activation of each CRL. We report herein the discovery of DI-1548 and DI-1859 as two potent, selective and covalent DCN1 inhibitors. These inhibitors selectively inhibit neddylation of cullin 3 in cells at low nanomolar concentrations and are 2–3 orders of magnitude more potent than our previously reported reversible DCN1 inhibitor. Mass spectrometric analysis and co-crystal structures reveal that these compounds employ a unique mechanism of covalent bond formation with DCN1. DI-1859 induces a robust increase of NRF2 protein, a CRL3 substrate, in mouse liver and effectively protects mice from acetaminophen-induced liver damage. Taken together, this study demonstrates the therapeutic potential of selective inhibition of cullin neddylation.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: USDOE Office of Science (SC); National Key Research and Development Program of China; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor

Grant/Contract Number:: AC02-06CH11357; 2016YFA0501800; 085P1000817

OSTI ID:: 1787786

Journal Information:: Nature Communications, Vol. 12, Issue 1; ISSN 2041-1723

Publisher:: Nature Publishing GroupCopyright Statement

Country of Publication:: United States

Language:: ENGLISH

References (46)

NEDD8 Pathways in Cancer, Sine Quibus Non Watson, Ian R.; Irwin, Meredith S.; Ohh, Michael Cancer Cell, Vol. 19, Issue 2 https://doi.org/10.1016/j.ccr.2011.01.002	journal	February 2011
Blocking an N-terminal acetylation–dependent protein interaction inhibits an E3 ligase Scott, Daniel C.; Hammill, Jared T.; Min, Jaeki Nature Chemical Biology, Vol. 13, Issue 8 https://doi.org/10.1038/nchembio.2386	journal	June 2017
Structure of a RING E3 Trapped in Action Reveals Ligation Mechanism for the Ubiquitin-like Protein NEDD8 Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K. Cell, Vol. 157, Issue 7 https://doi.org/10.1016/j.cell.2014.04.037	journal	June 2014
Targeted Covalent Inhibitors for Drug Design Baillie, Thomas A. Angewandte Chemie International Edition, Vol. 55, Issue 43 https://doi.org/10.1002/anie.201601091	journal	August 2016
Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy Zhao, Yongchao; Morgan, Meredith A.; Sun, Yi Antioxidants & Redox Signaling, Vol. 21, Issue 17 https://doi.org/10.1089/ars.2013.5795	journal	December 2014
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a ]pyrimidine-Based Inhibitors Targeting the DCN1–UBC12 Protein–Protein Interaction Wang, Shuai; Zhao, Lijie; Shi, Xiao-Jing Journal of Medicinal Chemistry, Vol. 62, Issue 5 https://doi.org/10.1021/acs.jmedchem.9b00113	journal	February 2019
Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation Kim, Ho Shin; Hammill, Jared T.; Scott, Daniel C. Journal of Medicinal Chemistry, Vol. 62, Issue 18 https://doi.org/10.1021/acs.jmedchem.9b00410	journal	August 2019
Cullin-RING Ligases as Attractive Anti-cancer Targets Zhao, Yongchao; Sun, Yi Current Pharmaceutical Design, Vol. 19, Issue 18 https://doi.org/10.2174/13816128113199990300	journal	April 2013
Proteasome inhibitors in cancer therapy Manasanch, Elisabet E.; Orlowski, Robert Z. Nature Reviews Clinical Oncology, Vol. 14, Issue 7 https://doi.org/10.1038/nrclinonc.2016.206	journal	January 2017
The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy Soucy, T. A.; Dick, L. R.; Smith, P. G. Genes & Cancer, Vol. 1, Issue 7 https://doi.org/10.1177/1947601910382898	journal	July 2010
MolProbity : all-atom structure validation for macromolecular crystallography Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042073	journal	December 2009
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang Analytical Biochemistry, Vol. 332, Issue 2 https://doi.org/10.1016/j.ab.2004.05.055	journal	September 2004
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets Bedford, Lynn; Lowe, James; Dick, Lawrence R. Nature Reviews Drug Discovery, Vol. 10, Issue 1 https://doi.org/10.1038/nrd3321	journal	December 2010
N-Terminal Acetylation Acts as an Avidity Enhancer Within an Interconnected Multiprotein Complex Scott, D. C.; Monda, J. K.; Bennett, E. J. Science, Vol. 334, Issue 6056 https://doi.org/10.1126/science.1209307	journal	September 2011
Function and regulation of cullin–RING ubiquitin ligases Petroski, Matthew D.; Deshaies, Raymond J. Nature Reviews Molecular Cell Biology, Vol. 6, Issue 1 https://doi.org/10.1038/nrm1547	journal	January 2005
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ Brownell, James E.; Sintchak, Michael D.; Gavin, James M. Molecular Cell, Vol. 37, Issue 1 https://doi.org/10.1016/j.molcel.2009.12.024	journal	January 2010
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina Science, Vol. 341, Issue 6141 https://doi.org/10.1126/science.1233606	journal	July 2013
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation Hammill, Jared T.; Bhasin, Deepak; Scott, Daniel C. Journal of Medicinal Chemistry, Vol. 61, Issue 7 https://doi.org/10.1021/acs.jmedchem.7b01282	journal	March 2018
NRF2 and the Hallmarks of Cancer Rojo de la Vega, Montserrat; Chapman, Eli; Zhang, Donna D. Cancer Cell, Vol. 34, Issue 1 https://doi.org/10.1016/j.ccell.2018.03.022	journal	July 2018
Protein neddylation and its alterations in human cancers for targeted therapy Zhou, Lisha; Zhang, Wenjuan; Sun, Yi Cellular Signalling, Vol. 44 https://doi.org/10.1016/j.cellsig.2018.01.009	journal	April 2018
A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation Zhou, Haibin; Lu, Jianfeng; Liu, Liu Nature Communications, Vol. 8, Issue 1 https://doi.org/10.1038/s41467-017-01243-7	journal	October 2017
Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR) Ward, Richard A.; Anderton, Mark J.; Ashton, Susan Journal of Medicinal Chemistry, Vol. 56, Issue 17 https://doi.org/10.1021/jm400822z	journal	August 2013
Drug discovery in the ubiquitin–proteasome system Nalepa, Grzegorz; Rolfe, Mark; Harper, J. Wade Nature Reviews Drug Discovery, Vol. 5, Issue 7 https://doi.org/10.1038/nrd2056	journal	July 2006
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1–UBE2M Interaction Zhou, Wenjuan; Ma, Liying; Ding, Lina Journal of Medicinal Chemistry, Vol. 62, Issue 11 https://doi.org/10.1021/acs.jmedchem.9b00003	journal	May 2019
Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present) Zhou, Haishan; Wang, Yan; You, Qidong Expert Opinion on Therapeutic Patents, Vol. 30, Issue 3 https://doi.org/10.1080/13543776.2020.1715365	journal	February 2020
Molecular replacement with MOLREP Vagin, Alexei; Teplyakov, Alexei Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042589	journal	December 2009
Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer Soucy, T. A.; Smith, P. G.; Rolfe, M. Clinical Cancer Research, Vol. 15, Issue 12 https://doi.org/10.1158/1078-0432.CCR-09-0343	journal	June 2009
A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8 Huang, Danny T.; Miller, David W.; Mathew, Rose Nature Structural & Molecular Biology, Vol. 11, Issue 10 https://doi.org/10.1038/nsmb826	journal	September 2004
The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle Hershko, A. Cell Death & Differentiation, Vol. 12, Issue 9 https://doi.org/10.1038/sj.cdd.4401702	journal	August 2005
Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation Hammill, Jared T.; Scott, Daniel C.; Min, Jaeki Journal of Medicinal Chemistry, Vol. 61, Issue 7 https://doi.org/10.1021/acs.jmedchem.7b01277	journal	March 2018
Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity Tsou, Hwei-Ru; Overbeek-Klumpers, Elsebe G.; Hallett, William A. Journal of Medicinal Chemistry, Vol. 48, Issue 4 https://doi.org/10.1021/jm040159c	journal	February 2005
High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein–Protein Interaction Zhou, Haibin; Zhou, Weihua; Zhou, Bing Journal of Medicinal Chemistry, Vol. 61, Issue 5 https://doi.org/10.1021/acs.jmedchem.7b01455	journal	January 2018
Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation Bulatov, Emil; Ciulli, Alessio Biochemical Journal, Vol. 467, Issue 3 https://doi.org/10.1042/BJ20141450	journal	April 2015
The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases Deshmukh, Prashant; Unni, Sruthi; Krishnappa, Gopinatha Biophysical Reviews, Vol. 9, Issue 1 https://doi.org/10.1007/s12551-016-0244-4	journal	December 2016
The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death Ciechanover, A.; Schwartz, A. L. Proceedings of the National Academy of Sciences, Vol. 95, Issue 6 https://doi.org/10.1073/pnas.95.6.2727	journal	March 1998
6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity Tsou, Hwei-Ru; Mamuya, Nellie; Johnson, Bernard D. Journal of Medicinal Chemistry, Vol. 44, Issue 17 https://doi.org/10.1021/jm0005555	journal	August 2001
Dcn1 Functions as a Scaffold-Type E3 Ligase for Cullin Neddylation Kurz, Thimo; Chou, Yang-Chieh; Willems, Andrew R. Molecular Cell, Vol. 29, Issue 1 https://doi.org/10.1016/j.molcel.2007.12.012	journal	January 2008
The resurgence of covalent drugs Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A. Nature Reviews Drug Discovery, Vol. 10, Issue 4 https://doi.org/10.1038/nrd3410	journal	April 2011
Drug discovery considerations in the development of covalent inhibitors Mah, Robert; Thomas, Jason R.; Shafer, Cynthia M. Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 1 https://doi.org/10.1016/j.bmcl.2013.10.003	journal	January 2014
[20] Processing of X-ray diffraction data collected in oscillation mode Otwinowski, Zbyszek; Minor, Wladek Macromolecular Crystallography Part A, 307-326 https://doi.org/10.1016/S0076-6879(97)76066-X	book	January 1997
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases Cuadrado, Antonio; Rojo, Ana I.; Wells, Geoffrey Nature Reviews Drug Discovery, Vol. 18, Issue 4 https://doi.org/10.1038/s41573-018-0008-x	journal	January 2019
A Dual E3 Mechanism for Rub1 Ligation to Cdc53 Scott, Daniel C.; Monda, Julie K.; Grace, Christy R. R. Molecular Cell, Vol. 39, Issue 5 https://doi.org/10.1016/j.molcel.2010.08.030	journal	September 2010
Structural Insights into NEDD8 Activation of Cullin-RING Ligases: Conformational Control of Conjugation Duda, David M.; Borg, Laura A.; Scott, Daniel C. Cell, Vol. 134, Issue 6 https://doi.org/10.1016/j.cell.2008.07.022	journal	September 2008
The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae Kurz, Thimo; Özlü, Nurhan; Rudolf, Fabian Nature, Vol. 435, Issue 7046 https://doi.org/10.1038/nature03662	journal	June 2005
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A. Nature, Vol. 458, Issue 7239 https://doi.org/10.1038/nature07884	journal	April 2009

Similar Records

High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein–Protein Interaction

Journal Article · Tue Feb 13 00:00:00 EST 2018 · Journal of Medicinal Chemistry · OSTI ID:1787786

Zhou, Haibin; Zhou, Weihua; Zhou, Bing; +11 more

Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation

Journal Article · Thu Aug 29 00:00:00 EDT 2019 · Journal of Medicinal Chemistry · OSTI ID:1787786

Kim, Ho Shin; Hammill, Jared T.; Scott, Daniel C.; +6 more

Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation

Journal Article · Fri Mar 16 00:00:00 EDT 2018 · Journal of Medicinal Chemistry · OSTI ID:1787786

Hammill, Jared T.; Scott, Daniel C.; Min, Jaeki; +8 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
neddylation
structure-based drug design
target validation
x-ray crystallography

Title: Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity

Citation Formats

References (46)

Similar Records

Related Subjects